
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Cdk7 CRISPR/Cas9 KO Plasmid (m) | sc-419606 | 20 µg | $397.00 | |||
Cdk7 HDR Plasmid (m) | sc-419606-HDR | 20 µg | $445.00 |
Cdk7 encodes cyclin-dependent kinase 7, a core component of the CDK-activating kinase (CAK) complex and a functional module of TFIIH that coordinates cell-cycle progression with transcription. CDK7 activates multiple CDKs via T-loop phosphorylation and contributes to RNA polymerase II CTD phosphorylation, coupling promoter clearance and transcriptional elongation with DNA repair processes. Through these roles, Cdk7 impacts checkpoints, replication stress responses, and genome stability in proliferating cells. Dysregulation of CDK7-associated signaling has been linked to altered cell proliferation programs and transcriptional dependency phenotypes relevant to cancer biology and developmental defects.
Cdk7 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Cdk7 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Cdk7 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, Cdk7 HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Cdk7 target site.
When co-transfected with Cdk7 CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Cdk7 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.